FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2020820110> ?p ?o ?g. }

• W2020820110 abstract "In diabetic patients, the combination of abciximab with stenting has been demonstrated to be the standard of care to reduce target vessel revascularization (TVR) and mortality. Moreover, a preprocedural hyperglycemia has been associated with a higher rate of TVR after an elective stent implantation. We sought to evaluate the effects of abciximab and/or preprocedural glycemic control on 30 and 180 days of TVR and on 1-year major adverse cardiac events (MACE-cardiac mortality, TVR, and myocardial infarction) in diabetic patients undergoing elective coronary stenting.From January 2002 through May 2003, diabetic patients undergoing elective stenting of de novo coronary artery lesions were randomized to abciximab or placebo infusion. Preprocedural hyperglycemia was defined as fasting plasma glucose >or=126 mg/dL (7.0 mmol/L) immediately before the procedure.A total of 122 consecutive patients with diabetes (62.4 +/- 10.2 years, 80 men) were enrolled in the study. Sixty-nine (56.5%) were randomly assigned to receive abciximab (34 with and 35 without preprocedural hyperglycemia) and 53 (43.5%) to placebo (23 with and 30 without hyperglycemia). Target vessel revascularization was significantly lower in diabetic patients who received abciximab at 30 days (2.9% and 2.8% vs 8.7% and 6.6% in nonabciximab group with or without hyperglycemia, respectively, P < .01) but not at 6 months (31.4% and 26.5% vs 30% and 28.7%, P = NS). Conversely, the cumulative incidence of MACE was significantly higher among diabetic patients with preprocedural hyperglycemia (64.7% and 65.2%) versus diabetic patients with preprocedural glycemic control (37.1% and 40%), treated with or without abciximab, respectively (P < .05).A preprocedural hyperglycemia is associated with a higher rate of MACE, regardless of the use of abciximab, in diabetic patients undergoing elective coronary stenting." @default.
• W2020820110 created "2016-06-24" @default.
• W2020820110 creator A5006527527 @default.
• W2020820110 creator A5062992974 @default.
• W2020820110 creator A5065764754 @default.
• W2020820110 creator A5068562796 @default.
• W2020820110 creator A5083290836 @default.
• W2020820110 date "2005-06-01" @default.
• W2020820110 modified "2023-09-26" @default.
• W2020820110 title "Effects of abciximab and preprocedural glycemic control in diabetic patients undergoing elective coronary stenting" @default.
• W2020820110 cites W1964511936 @default.
• W2020820110 cites W1964771459 @default.
• W2020820110 cites W1965330483 @default.
• W2020820110 cites W1977163871 @default.
• W2020820110 cites W1977670982 @default.
• W2020820110 cites W1982122174 @default.
• W2020820110 cites W1987651688 @default.
• W2020820110 cites W1992188034 @default.
• W2020820110 cites W2005998137 @default.
• W2020820110 cites W2011505588 @default.
• W2020820110 cites W2028202875 @default.
• W2020820110 cites W2034051654 @default.
• W2020820110 cites W2036720093 @default.
• W2020820110 cites W2036872051 @default.
• W2020820110 cites W2047717686 @default.
• W2020820110 cites W2052893559 @default.
• W2020820110 cites W2059136191 @default.
• W2020820110 cites W2059601021 @default.
• W2020820110 cites W2060607835 @default.
• W2020820110 cites W2062175172 @default.
• W2020820110 cites W2067925813 @default.
• W2020820110 cites W2079160097 @default.
• W2020820110 cites W2081799397 @default.
• W2020820110 cites W2090031801 @default.
• W2020820110 cites W2090824142 @default.
• W2020820110 cites W2093383681 @default.
• W2020820110 cites W2106603497 @default.
• W2020820110 cites W2120786522 @default.
• W2020820110 cites W2128715802 @default.
• W2020820110 cites W2138893124 @default.
• W2020820110 cites W2142920442 @default.
• W2020820110 cites W2153089743 @default.
• W2020820110 cites W2153314625 @default.
• W2020820110 cites W2154257241 @default.
• W2020820110 cites W215666229 @default.
• W2020820110 cites W2156949831 @default.
• W2020820110 cites W2166597533 @default.
• W2020820110 cites W2206606798 @default.
• W2020820110 cites W2274004819 @default.
• W2020820110 cites W2323060881 @default.
• W2020820110 cites W2324899882 @default.
• W2020820110 cites W2331274940 @default.
• W2020820110 cites W2162886638 @default.
• W2020820110 doi "https://doi.org/10.1016/j.ahj.2005.02.015" @default.
• W2020820110 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15976799" @default.
• W2020820110 hasPublicationYear "2005" @default.
• W2020820110 type Work @default.
• W2020820110 sameAs 2020820110 @default.
• W2020820110 citedByCount "13" @default.
• W2020820110 countsByYear W20208201102013 @default.
• W2020820110 crossrefType "journal-article" @default.
• W2020820110 hasAuthorship W2020820110A5006527527 @default.
• W2020820110 hasAuthorship W2020820110A5062992974 @default.
• W2020820110 hasAuthorship W2020820110A5065764754 @default.
• W2020820110 hasAuthorship W2020820110A5068562796 @default.
• W2020820110 hasAuthorship W2020820110A5083290836 @default.
• W2020820110 hasBestOaLocation W20208201102 @default.
• W2020820110 hasConcept C126322002 @default.
• W2020820110 hasConcept C134018914 @default.
• W2020820110 hasConcept C141071460 @default.
• W2020820110 hasConcept C142724271 @default.
• W2020820110 hasConcept C164705383 @default.
• W2020820110 hasConcept C204787440 @default.
• W2020820110 hasConcept C27081682 @default.
• W2020820110 hasConcept C2777871224 @default.
• W2020820110 hasConcept C2778213512 @default.
• W2020820110 hasConcept C2779306644 @default.
• W2020820110 hasConcept C2780400711 @default.
• W2020820110 hasConcept C2780473172 @default.
• W2020820110 hasConcept C2780739214 @default.
• W2020820110 hasConcept C500558357 @default.
• W2020820110 hasConcept C555293320 @default.
• W2020820110 hasConcept C71924100 @default.
• W2020820110 hasConceptScore W2020820110C126322002 @default.
• W2020820110 hasConceptScore W2020820110C134018914 @default.
• W2020820110 hasConceptScore W2020820110C141071460 @default.
• W2020820110 hasConceptScore W2020820110C142724271 @default.
• W2020820110 hasConceptScore W2020820110C164705383 @default.
• W2020820110 hasConceptScore W2020820110C204787440 @default.
• W2020820110 hasConceptScore W2020820110C27081682 @default.
• W2020820110 hasConceptScore W2020820110C2777871224 @default.
• W2020820110 hasConceptScore W2020820110C2778213512 @default.
• W2020820110 hasConceptScore W2020820110C2779306644 @default.
• W2020820110 hasConceptScore W2020820110C2780400711 @default.
• W2020820110 hasConceptScore W2020820110C2780473172 @default.
• W2020820110 hasConceptScore W2020820110C2780739214 @default.
• W2020820110 hasConceptScore W2020820110C500558357 @default.
• W2020820110 hasConceptScore W2020820110C555293320 @default.
• W2020820110 hasConceptScore W2020820110C71924100 @default.
• W2020820110 hasLocation W20208201101 @default.

• next